Pancreatic cancer is one of the worsts. It is often detected late, spreads rapidly, and has a poor prognosis. There are no symptoms in the early stages. Later stages are associated with symptoms, but these can be non-specific. New treatments are badly needed. Singh Biotechnology is developing a new treatment approach that can shut off the “master switch” that controls cancer growth. This is could revolutionize how we treat deadly cancers like pancreatic.